Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Tuspetinib

Tuspetinib (HM43239) is an orally active and selective FLT3 inhibitor with IC50s of 1.1 nM, 1.8 nM and 1.0 nM for FLT3 WT, FLT3 internal tandem duplication (ITD) and FLT3 D835Y kinases, respectively. Tuspetinib inhibits the kinase activity of FLT3 as a reversible type I inhibitor and modulates p-STAT5, p-ERK, SYK, JAK1/2, and TAK1. Tuspetinib inhibits the proliferation and induces the apoptosis of leukemic cells[1][2][3].

Product Specifications

CAS Number

[2294874-49-8]

Product Name Alternative

HM43239

UNSPSC

12352005

Hazard Statement

H302, H315, H319

Target

Apoptosis; FLT3

Type

Reference compound

Related Pathways

Apoptosis; Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/tuspetinib.html

Purity

99.85

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

ClC1=CN=C(NC2=CC(C3CC3)=CC(CN4C[C@H](N[C@H](C4)C)C)=C2)N=C1C5=CNC6=CC(C)=CC=C56

Molecular Formula

C29H33ClN6

Molecular Weight

501.07

Precautions

H302, H315, H319

References & Citations

[1]Miyoung Lee, et.al. Abstract 804: Antitumor activity of the potent and novel FLT3 inhibitor HM43239 in acute myeloid leukemia. Cancer Res July 1 2018 (78) (13 Supplement) 804.|[2]Naval G. Daver, et.al. HM43239, a Novel Potent Small Molecule FLT3 Inhibitor, in Acute Myeloid Leukemia (AML) with FMS-like Tyrosine Kinase 3 (FLT3) Mutations: Phase 1 /2 Study. Blood 2019; 134 (Supplement_1) : 1331.|[3]JiSook Kim, et.al. Abstract 1293: HM43239, a novel FLT3 inhibitor in overcoming resistance for acute myeloid leukemia. Cancer Res July 1 2019 (79) (13 Supplement) 1293.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, protect from light)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-145015/Tuspetinib-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-145015/Tuspetinib-SDS-MedChemExpress.pdf

Scientific Category

Reference compound1

Clinical Information

Phase 2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Anti-MARVELD2 Antibody Picoband®, Carrier-free
A05714-1-carrier-free 100 µg/Vial

Anti-MARVELD2 Antibody Picoband®, Carrier-free

Ask
View Details
TRML2 Antibody
C46863-01 50 µL

TRML2 Antibody

Ask
View Details
TRML2 Antibody
C46863-02 100 µL

TRML2 Antibody

Ask
View Details
Recombinant Escherichia coli O7:K1 L-carnitine/gamma-butyrobetaine antiporter (caiT), partial
MBS1058654-01 1 mg (E-Coli)

Recombinant Escherichia coli O7:K1 L-carnitine/gamma-butyrobetaine antiporter (caiT), partial

Ask
View Details
Recombinant Escherichia coli O7:K1 L-carnitine/gamma-butyrobetaine antiporter (caiT), partial
MBS1058654-02 1 mg (Yeast)

Recombinant Escherichia coli O7:K1 L-carnitine/gamma-butyrobetaine antiporter (caiT), partial

Ask
View Details
CF 1743-d7
HY-W770090 1 Each

CF 1743-d7

Ask
View Details